Pfizer Drops Pursuit Of AstraZeneca
Pfizer quit its months-long pursuit of rival AstraZeneca Monday, officially declaring it does not intend to make a new offer after the British drugmaker’s rejection of its $119 billion bid last week. Pfizer had described its latest offer as final and said it would not pursue a hostile deal if AstraZeneca declined to open formal negotiations. After it was rebuffed, Pfizer went public with a $100 billion cash-and-stock offer for the company in late April.
“Pfizer Drops Pursuit Of AstraZeneca” is categorized as “business”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.